ATOPIC dermatitis (AD) is a chronic inflammatory skin condition that significantly impacts patients’ quality of life. It is ...

Recent findings from the RESOLVE-1 trial highlight mycophenolate mofetil's efficacy in treating diffuse cutaneous systemic ...

A phase 3 trial confirms delgocitinib cream is safe and effective for long-term treatment of chronic hand eczema, maintaining disease control for up to 52 weeks.

A major meta-analysis of 1.3 million patients confirms remdesivir improves COVID-19 survival. But are treatment guidelines keeping up with the evidence?

Experts stress the need for diversity in basic and clinical research, highlighting recruitment challenges, mentorship gaps, ...

Guttman-Yassky received research support, consulting, or lecture fees on atopic dermatitis from Regeneron, Sanofi, Pfizer, ...

A recent study reveals that nearly half of family surrogate decision-makers for stroke patients face substantial financial ...

BLADDER cancer is classified as either non-muscle invasive bladder cancer (NMIBC) or muscle-invasive bladder cancer (MIBC) ...

Preliminary results from the MITO 40 study presented at ESGO 2025 suggest Niraparib as a promising maintenance treatment for ...

Study presented at ESGO 2025 highlights the accuracy of preoperative tumour size assessment in stage IB2 cervical cancer and ...

A LARGE cohort study of 221,054 US adults has revealed that higher butter intake is associated with increased mortality, ...

A DMT-based treatment for people with treatment-resistant depression (TRD) has entered Phase 2 clinical trials.